Home » Topics » Regulatory

Regulatory
RSS

Topiramate now claimed effective in schizophrenia

July 4, 2000

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

July 4, 2000

CPMP recommends approval of Caelyx for treatment of advanced ovarian cancer

July 3, 2000

FDA approves Bayer's next-generation hemophilia A treatment

June 30, 2000

FDA approves first drug to treat growth failure in children with Prader-Willi syndrome

June 30, 2000

Nutropin Depot now available

June 29, 2000

Lilly claims new uses for LY-203638

June 29, 2000

Eniporide now claimed to be useful in NIDDM

June 29, 2000

Use of seratrodast for COPD supported by clinical results

June 28, 2000

Riluzole + alpha-tocopherol delays progression of ALS more frequently than riluzole alone

June 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...